Psychosocial interventions offered limited benefits for reducing symptoms and substance use in patients with schizophrenia and comorbid substance use disorder.

Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is ...

In the wake of the approval Bristol Myers Squibb’s Cobenfy, it seems that news has ramped up in the schizophrenia space. The latest contender is Reviva Pharmaceuticals’ brilaroxazine, which reduced ...

This is the first study of infliximab in this patient population and designed to test whether the impact of inflammation on this circuit and these symptoms may be causal. "There is an urgent need to ...

Can the right diet "cure" schizophrenia? Despite provocative case studies, research to date indicates we do not know.

Early-20th-century anatomical illustration of the human brain showing the cerebellum (Latin for "little brain") and prefrontal cortex from below. "Cerebellar" means 'relating to or located in the ...

US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

Robert F. Kennedy Jr. has recently promoted the unproven claim that keto diets can “cure schizophrenia,” and while scientists disagree with the Health and Human Services Secretary, emerging research ...

A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in ...